Stay updated on Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page
- ChecktodayChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5. This reflects a new version of the page and does not appear to change study data or visible content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision number was updated from v3.5.3 to v3.5.4, indicating a minor backend/template update that does not change the displayed study details.SummaryDifference0.1%

- Check43 days agoChange DetectedThis updates the ClinicalTrials.gov page’s display revision/version in the footer from v3.5.2 to v3.5.3, without changing any study details or record information.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check86 days agoChange DetectedPage revision updated to v3.4.3 with new dates (2026-03-03, 2026-03-05, 2026-03) and the previous revision v3.4.2 removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.